Valuation: CeriBell, Inc.

Market Cap 929M 796M 744M 681M 1.28B 88.86B 1.3B 8.79B 3.43B 44.64B 3.49B 3.41B 148B P/E 2026 *
-12.3x
P/E 2027 * -15.5x
Enterprise Value 934M 800M 748M 685M 1.29B 89.33B 1.3B 8.84B 3.45B 44.87B 3.51B 3.43B 148B EV / Sales 2026 *
8.08x
EV / Sales 2027 * 6.52x
Free-Float
87.97%
Yield 2026 *
-
Yield 2027 * -
1 day-0.45%
1 week+3.73%
Current month+36.80%
1 month+43.88%
3 months+28.93%
6 months+19.68%
Current year+10.35%
1 week 22.98
Extreme 22.98
25.33
1 month 16.1
Extreme 16.1
25.33
Current year 15.84
Extreme 15.84
25.33
1 year 10.85
Extreme 10.85
25.33
3 years 10.01
Extreme 10.01
32.75
5 years 10.01
Extreme 10.01
32.75
10 years 10.01
Extreme 10.01
32.75
Manager TitleAgeSince
Chief Executive Officer 46 2015-09-30
Director of Finance/CFO 44 2020-03-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 46 2014-08-28
Chairman 57 2014-08-28
Director/Board Member 64 2021-03-31
Date Insider Type Main position Quantity % Market Cap.
8/19/26 Fiscal year

Chief Financial Officer

100,536 0.2650%
8/19/26 Sell

Founder

-31,415 0.0828%
8/13/26 Fiscal year

Founder

66,192 0.1745%
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%+3.73%+100.66% - 929M
+0.42%+1.65%-24.01%+20.06% 4.24B
-0.99%-3.68%+45.30% - 1.58B
+1.60%+0.40%-6.10%+0.20% 149M
-5.42%-12.10%+65.15%+57.12% 116M
+7.60%-6.57%-21.75%-30.24% 51M
Average +0.46%-2.76%+26.54%+11.78% 1.18B
Weighted average by Cap. -0.03%+0.42%+9.77%+19.79%

Financials

2026 *2027 *
Net sales 115M 98.92M 92.55M 84.72M 159M 11.05B 161M 1.09B 426M 5.55B 434M 424M 18.36B 147M 126M 118M 108M 203M 14.07B 205M 1.39B 543M 7.07B 552M 540M 23.38B
Net income -75.94M -65.05M -60.87M -55.72M -105M -7.27B -106M -719M -280M -3.65B -285M -279M -12.07B -61.91M -53.03M -49.62M -45.42M -85.25M -5.92B -86.37M -586M -229M -2.98B -232M -227M -9.84B
Net Debt 4.85M 4.15M 3.88M 3.56M 6.67M 464M 6.76M 45.9M 17.9M 233M 18.2M 17.8M 771M 29.76M 25.49M 23.85M 21.83M 40.97M 2.85B 41.52M 282M 110M 1.43B 112M 109M 4.73B
Logo CeriBell, Inc.
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its hardware is composed of disposable, flexible headbands and head caps (Wearables) and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals. EEG data captured by the recorder are interpreted by its proprietary AI-powered seizure detection algorithms, which monitor the patient’s EEG signal and support the clinician’s real-time assessment of seizure activity.
Employees
327
Date Price Change Volume
26-08-21 US$24.20 -0.45% 292,626
26-08-20 US$24.31 -2.33% 262,277
26-08-19 US$24.89 +2.81% 845,352
26-08-18 US$24.21 -0.78% 450,190
26-08-17 US$24.40 +4.59% 396,319
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
24.20USD
Average target price
27.29USD
Spread / Average Target
+12.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CBLL Stock